1. Two-month follow-up of persons with SARS-CoV-2 infection-Zambia, September 2020: a cohort study
- Author
-
James Exnobert Zulu, Dabwitso Banda, Jonas Zajac Hines, Musisye Luchembe, Suilanje Sivile, Mpanji Siwingwa, Davies Kampamba, Khozya Davie Zyambo, Robert Chirwa, Lameck Chirwa, Warren Malambo, Danielle Barradas, Nyambe Sinyange, Simon Agolory, Lloyd Berdad Mulenga, and Sombo Fwoloshi
- Subjects
Cohort Studies ,Zambia ,COVID-19 ,SARS-CoV-2 ,cough ,follow-up study ,headache ,long COVID ,Humans ,General Medicine ,Follow-Up Studies - Abstract
Introduction:COVID-19 is often characterized by an acute upper respiratory tract infection. However, information on longer-term clinical sequelae following acute COVID-19 is emerging. We followed a group of persons with COVID-19 in Zambia at two months to assess persistent symptoms. Methods:in September 2020, we re-contacted participants from SARS-CoV-2 prevalence studies conducted in Zambia in July 2020 whose polymerase chain reaction (PCR) tests were positive. Participants with valid contact information were interviewed using a structured questionnaire that captured demographics, pre-existing conditions, and types and duration of symptoms. We describe the frequency and duration of reported symptoms and used chi-square tests to explore variability of symptoms by age group, gender, and underlying conditions. Results:of 302 participants, 155 (51%) reported one or more acute COVID-19-related symptoms in July 2020. Cough (50%), rhinorrhoea (36%) and headache (34%) were the most frequently reported symptoms proximal to diagnosis. The median symptom duration was 7 days (IQR: 3-9 days). At a median follow up of 54 days (IQR: 46-59 day), 27 (17%) symptomatic participants had not yet returned to their pre-COVID-19 health status. These participants most commonly reported cough (37%), headache (26%) and chest pain (22%). Age, sex, and pre-existing health conditions were not associated with persistent symptoms. Conclusion:a notable percentage of persons with SARS-CoV-2 infection in July still had symptoms nearly two months after their diagnosis. Zambia is implementing ´post-acute COVID-19 clinics´ to care for patients with prolonged symptoms of COVID-19, to address their needs and better understand how the disease will impact the population over time.
- Published
- 2022